Patent Assignment
Reel/Frame 040398/0431
Assignment of Assignor's Interest
Recorded: 2016-11-22
Pages: 8
Assignors
WINKLER, DAVID G.
Executed: 2008-04-07
SHI, JIYE
Executed: 2008-04-14
LATHAM, JOHN
Executed: 2008-04-07
Assignee
CELLTECH R&D, INC.
1631 220TH STREET S.E., BOTHELL, WASHINGTON, 98201
Covered Properties
(7)
Immunogenic Peptides Derived from Sclerostin
Polynucleotides Encoding Antibodies Specific for Sclerostin
Application:
12/958,195 →
Publication:
US 2011/0195453
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application:
13/101,434 →
Publication:
US 2011/0206677
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application:
13/101,455 →
Publication:
US 2011/0206678
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assets into Darwin Molecular Corporation
Sep 29, 2010
From: CELLTECH R&D, INC.
To: DARWIN MOLECULAR CORPORATION
Reel/Frame 025051/0949 →
Merger
Sep 29, 2010
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 025051/0957 →
Assignment of Assignor's Interest
Aug 12, 2014
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 033516/0493 →
Merger
Nov 22, 2016
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 040398/0489 →
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assets into Darwin Molecular Corporation
Nov 22, 2016
From: CELLTECH R&D, INC.
To: DARWIN MOLECULAR CORPORATION
Reel/Frame 040662/0916 →